GlassScriptPhysician profile
James P Bradley
NPI 1083607196
$1,499.64
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $785 · 2020: $715.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $688.63 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $277.22 | 2019 | |
| Glaxosmithkline, LLC. | $191.42 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.45 | 2019-2020 | |
| Allergan, INC. | $34.45 | 2019 | |
| Grifols USA, LLC | $32.63 | 2019 | |
| Shire North American Group INC | $28.23 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.50 | 2019 | |
| Mylan Specialty L.P. | $15.36 | 2019 | |
| Circassia INC. | $15.28 | 2019 | |
| Merck Sharp & Dohme LLC | $14.01 | 2019 | |
| Sunovion Pharmaceuticals INC. | $12.75 | 2019 | |
| Jazz Pharmaceuticals INC. | $12.50 | 2019 | |
| Abbott Laboratories | $11.21 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bradley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.